Principal Investigator
Peter Hosein
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20260199
Clinical Trial Summary
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or
Without INCB161734 in Previously Untreated, KRAS G12D–Mutated
Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Stomach and Esophageal Cancer
Contact Information
Phone Number
305-243-2647